Opposing consequences of IL-23 signaling mediated by innate and adaptive cells in chemically induced colitis in mice

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Mucosal Immunology

• Publication date

  2011-11-16

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/mi.2011.54PMID 22089030
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• RORγt+ innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota

  2011cited by this paper
• CD4(+) lymphoid tissue-inducer cells promote innate immunity in the gut.

  2011cited by this paper
• Generation of Pathogenic Th17 Cells in the Absence of TGF-β Signaling

  2010cited by this paper
• Future biologic targets for IBD: potentials and pitfalls

  2010cited by this paper
• Innate lymphoid cells drive IL-23 dependent innate intestinal pathology

  2010cited by this paper
• Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A

  2010cited by this paper
• Cutting Edge: IL-23 Receptor GFP Reporter Mice Reveal Distinct Populations of IL-17-Producing Cells1

  2009cited by this paper
• STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing

  2009cited by this paper
• A protective function for interleukin 17A in T cell–mediated intestinal inflammation

  2009cited by this paper
• The genetics of Crohn's disease.

  2009cited by this paper
• A Large-Scale Genetic Association Study Confirms IL12B and Leads to the Identification of IL23R as Psoriasis-Risk Genes

  2008cited by this paper
• Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface

  2008cited by this paper
• IL-23 Promotes Maintenance but Not Commitment to the Th17 Lineage1

  2008cited by this paper
• Regulation of inflammatory responses by IL-17F

  2008cited by this paper
• Interleukin-23 Restrains Regulatory T Cell Activity to Drive T Cell-Dependent Colitis

  2008cited by this paper
• A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease.

  2008cited by this paper
• Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens

  2008cited by this paper
• Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease.

  2008cited by this paper
• Validation of murine dextran sulfate sodium-induced colitis using four therapeutic agents for human inflammatory bowel disease.

  2008cited by this paper
• Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease

  2008cited by this paper
• Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice.

  2007cited by this paper
• A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene.

  2007cited by this paper
• Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis

  2007cited by this paper
• MyD88-mediated signals induce the bactericidal lectin RegIIIγ and protect mice against intestinal Listeria monocytogenes infection

  2007cited by this paper
• A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes.

  2007cited by this paper
• Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants

  2007cited by this paper
• Interleukin-23 drives innate and T cell–mediated intestinal inflammation

  2006cited by this paper
• IL-23 plays a key role in Helicobacter hepaticus–induced T cell–dependent colitis

  2006cited by this paper
• Cutting Edge: IL-23 Cross-Regulates IL-12 Production in T Cell-Dependent Experimental Colitis1

  2006cited by this paper
• Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides

  2006cited by this paper
• Symbiotic Bacteria Direct Expression of an Intestinal Bactericidal Lectin

  2006cited by this paper
• Transforming growth factor-beta induces development of the T(H)17 lineage.

  2006cited by this paper
• A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene

  2006cited by this paper
• Cutting edge: IL-23 cross-regulates IL-12 production in T cell-dependent experimental colitis.

  2006cited by this paper
• Compromised Humoral and Delayed-Type Hypersensitivity Responses in IL-23-Deficient Mice1

  2004cited by this paper
• Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut

  2004cited by this paper
• Anti-interleukin-12 antibody for active Crohn's disease.

  2004cited by this paper
• Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain

  2003cited by this paper
• Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation

  2003cited by this paper
• A Receptor for the Heterodimeric Cytokine IL-23 Is Composed of IL-12Rβ1 and a Novel Cytokine Receptor Subunit, IL-23R1

  2002cited by this paper
• Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12.

  2000cited by this paper
• Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin.

  1997cited by this paper
• Dextran sulfate sodium (DSS) induced experimental colitis in immunodeficient mice: Effects in CD4+-cell depleted, athymic and NK-cell depleted SCID mice

  1996cited by this paper
• T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines

  1996cited by this paper
• Clinicopathologic study of dextran sulfate sodium experimental murine colitis.

  1993cited by this paper

• The gut-organ axis: Clinical aspects and immune mechanisms.

  2025cites this paper
• Phantom of the immunologic opera: Unmasking the role of innate lymphoid cells (ILC) in inborn errors of immunity (IEI)

  2025cites this paper
• Engineering a protease-stable, oral single-domain antibody to inhibit IL-23 signaling

  2025cites this paper
• Neutrophils disrupt the intestinal barrier via IL-22/TGF-β/Mmp9 axis in the zebrafish model of inflammatory bowel disease.

  2025cites this paper
• A little ER stress isn’t bad: the IRE1α/XBP1 pathway shapes ILC3 functions during intestinal inflammation

  2024cites this paper
• Targeting the IL-23 Pathway in Inflammatory Bowel Disease.

  2024cites this paper
• CTLA-4-expressing ILC3s restrain interleukin-23-mediated inflammation

  2024cites this paper
• Investigating the impact of antibiotic-induced dysbiosis on protection from Clostridium difficile colitis by mouse colonic innate lymphoid cells

  2024cites this paper
• IL-23 Exerts Dominant Pathogenic Functions in Crohn's Disease-Ileitis.

  2024cites this paper
• Exploring the Interplay Between Cancer, Health, and Inflammation

  2024cites this paper
• Type 17 immunity: novel insights into intestinal homeostasis and autoimmune pathogenesis driven by gut-primed T cells

  2024cites this paper
• Human IL-22 receptor-targeted small protein antagonist suppress murine DSS-induced colitis

  2024cites this paper
• Dose escalation randomised study of efmarodocokin alfa in healthy volunteers and patients with ulcerative colitis

  2023cites this paper
• Targeting IL-23 for IBD: Rationale and Progress to Date

  2023cites this paper
• IL-12 and IL-23 pathway inhibition in inflammatory bowel disease

  2023cites this paper
• Evaluation of circulating innate lymphoid cells in the early pathogenesis of mouse colorectal carcinoma

  2023cites this paper
• Network Approaches to Uncover Pathogenesis and Therapeutic Targets of Inflammatory Bowel Diseases.

  2023cites this paper
• Interleukin-23 receptor signaling impairs the stability and function of colonic regulatory T cells

  2023cites this paper
• GM‐CSF‐producing CCR2+CCR6+ Th17 cells are pathogenic in dextran sodium sulfate‐induced colitis model in mice

  2023influential citation
• Nanoparticles Carrying NF-κB p65-Specific siRNA Alleviate Colitis in Mice by Attenuating NF-κB-Related Protein Expression and Pro-Inflammatory Cellular Mediator Secretion

  2022cites this paper
• Epithelial dysfunction is prevented by IL-22 treatment in a Citrobacter rodentium-induced colitis model that shares similarities with inflammatory bowel disease

  2022cites this paper
• Optimized human intestinal organoid model reveals interleukin-22-dependency of paneth cell formation

  2022cites this paper
• Regulation of intestinal immunity by dietary fatty acids

  2022cites this paper
• Pattern Recognition Receptor Signaling and Cytokine Networks in Microbial Defenses and Regulation of Intestinal Barriers: Implications for Inflammatory Bowel Disease.

  2022cites this paper
• Innate Lymphoid Cells as Regulators of Epithelial Integrity: Therapeutic Implications for Inflammatory Bowel Diseases

  2021cites this paper
• Amelioration of DSS-Induced Acute Colitis in Mice by Recombinant Monomeric Human Interleukin-22

  2021cites this paper
• Diet-Host-Microbiota Interactions Shape Aryl Hydrocarbon Receptor Ligand Production to Modulate Intestinal Homeostasis.

  2021influential citation
• Innate lymphoid cells are double‐edged swords under the mucosal barrier

  2021cites this paper
• mTOR signaling mediates ILC3-driven immunopathology

  2021cites this paper
• The IL23-IL17 Immune Axis in the Treatment of Ulcerative Colitis: Successes, Defeats, and Ongoing Challenges

  2021cites this paper
• Interleukin-22 Attenuates Acute Pancreatitis-Associated Intestinal Mucosa Injury in Mice via STAT3 Activation

  2021cites this paper
• The role of IL-22 in intestinal health and disease

  2020cites this paper
• All are Equal, Some are More Equal: Targeting IL 12 and 23 in IBD – A Clinical Perspective

  2020cites this paper
• The Importance of Hypoxia-Inducible Factors (HIF-1 and HIF-2) for the Pathophysiology of Inflammatory Bowel Disease

  2020cites this paper
• IL-18/IL-18BP and IL-22/IL-22BP: Two interrelated couples with therapeutic potential.

  2019cites this paper
• IL-23 in inflammatory bowel diseases and colon cancer.

  2019cites this paper
• Fingolimod Alters Tissue Distribution and Cytokine Production of Human and Murine Innate Lymphoid Cells

  2019cites this paper
• Interleukin-22 regulates the homeostasis of the intestinal epithelium during inflammation

  2019cites this paper
• Induced and spontaneous colitis mouse models reveal complex interactions between IL-10 and IL-12/IL-23 pathways.

  2019cites this paper
• Targeting immune cell circuits and trafficking in inflammatory bowel disease

  2019cites this paper
• Temporally Distinct Functions of the Cytokines IL-12 and IL-23 Drive Chronic Colon Inflammation in Response to Intestinal Barrier Impairment.

  2019cites this paper
• Chapter 5 Interleukin 23 in IBD Pathogenesis

  2019influential citation
• Critical Roles of Balanced Innate Lymphoid Cell Subsets in Intestinal Homeostasis, Chronic Inflammation, and Cancer

  2019cites this paper
• The Role of Immune Cells and Cytokines in Intestinal Wound Healing

  2019cites this paper
• Effect of Homocysteine on the Differentiation of CD4+ T Cells into Th17 Cells

  2018cites this paper
• Investigational drugs in phase I and phase II clinical trials targeting interleukin 23 (IL23) for the treatment of Crohn’s disease

  2018cites this paper
• Reduced monocyte and macrophage TNFSF15/TL1A expression is associated with susceptibility to inflammatory bowel disease

  2018cites this paper
• The class I myosin MYO1D binds to lipid and protects against colitis

  2018cites this paper
• Defining the role of NCR- ILC3s in chronic colitis

  2018cites this paper
• Immunotherapy in inflammatory bowel disease: Novel and emerging treatments

  2018cites this paper
• The Tumor Necrosis Factor Superfamily Member RANKL Suppresses Effector Cytokine Production in Group 3 Innate Lymphoid Cells

  2018cites this paper
• Diet Modifies Colonic Microbiota and CD4+ T Cell Repertoire to Trigger Flares in a Novel Model of Colitis Induced by IL-23

  2018cites this paper
• Diet Modifies Colonic Microbiota and CD4+ T-Cell Repertoire to Induce Flares of Colitis in Mice With Myeloid-Cell Expression of Interleukin 23.

  2018cites this paper
• Molecular characteristics of rhesus macaque interleukin‐22: cloning, in vitro expression and biological activities

  2018cites this paper
• The Complex Interplay between Chronic Inflammation, the Microbiome, and Cancer: Understanding Disease Progression and What We Can Do to Prevent It

  2018cites this paper
• Experimental Lung Metastases in Mice Are More Effectively Inhibited by Blockade of IL23R than IL23

  2018cites this paper
• Role of interferon‐γ and inflammatory monocytes in driving colonic inflammation during acute Clostridium difficile infection in mice

  2017cites this paper
• Anti-inflammatory natural product goniothalamin reduces colitis-associated and sporadic colorectal tumorigenesis

  2017cites this paper
• Knockdown of myeloid cell hypoxia-inducible factor-1α ameliorates the acute pathology in DSS-induced colitis

  2017cites this paper
• Innate Lymphoid Cells (Non‐NK ILCs)

  2017cites this paper
• The role of TCR signals and downstream events for NKT and regulatory T cell identity and function in the mouse

  2017cites this paper
• Innate Lymphoid Cells in HIV/SIV Infections

  2017cites this paper
• Regulation of IL-12p40 by HIF controls Th1/Th17 responses to prevent mucosal inflammation

  2017cites this paper
• RIP3 deficiency exacerbates inflammation in dextran sodium sulfate‐induced ulcerative colitis mice model

  2017cites this paper
• Lessons Learned From Trials Targeting Cytokine Pathways in Patients With Inflammatory Bowel Diseases.

  2017cites this paper
• IgA-coated E. coli enriched in Crohn’s disease spondyloarthritis promote TH17-dependent inflammation

  2017cites this paper
• Clinical importance of IL-22 cascade in IBD

  2017cites this paper
• Cytokines IL-17 and IL-22 in the host response to infection

  2016cites this paper
• Expression of the novel adipokine C1qTNF-related protein 4 (CTRP4) suppresses colitis and colitis-associated colorectal cancer in mice

  2016cites this paper
• Though Active on RINm5F Insulinoma Cells and Cultured Pancreatic Islets, Recombinant IL-22 Fails to Modulate Cytotoxicity and Disease in a Protocol of Streptozotocin-Induced Experimental Diabetes

  2016cites this paper
• HMGB1 exacerbates experimental mouse colitis by enhancing innate lymphoid cells 3 inflammatory responses via promoted IL-23 production

  2016cites this paper
• Interleukin 23 in IBD Pathogenesis

  2016influential citation
• Postbiotic Modulation of Retinoic Acid Imprinted Mucosal-like Dendritic Cells by Probiotic Lactobacillus reuteri 17938 In Vitro

  2016cites this paper
• Function and plasticity of NKp46 expressing innate lymphoid cells

  2016cites this paper
• CD45 regulates GM-CSF, retinoic acid and T-cell homing in intestinal inflammation

  2016cites this paper
• Interleukin‐23 (IL‐23), independent of IL‐17 and IL‐22, drives neutrophil recruitment and innate inflammation during Clostridium difficile colitis in mice

  2016cites this paper
• Epithelial IL-23R Signaling Licenses Protective IL-22 Responses in Intestinal Inflammation.

  2016influential citation
• Increased Expression of DUOX2 Is an Epithelial Response to Mucosal Dysbiosis Required for Immune Homeostasis in Mouse Intestine.

  2015cites this paper
• Ror-gamma T inhibition as a Pharmacological Approach for Inflammatory Bowel Disease

  2015cites this paper
• Integrating the pathogenesis of spondyloarthritis: gut and joint united?

  2015cites this paper
• Cytokines, IBD, and Colitis-associated Cancer

  2015cites this paper
• Intestinal Epithelial Cell Tyrosine Kinase 2 Transduces IL-22 Signals To Protect from Acute Colitis

  2015cites this paper
• This information is current as Acute Colitis Transduces IL-22 Signals To Protect from Intestinal Epithelial Cell Tyrosine Kinase 2

  2015cites this paper
• Innate lymphoid cells in intestinal immunity and inflammation

  2015cites this paper
• Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability.

  2015cites this paper
• Preclinical development of AMG 139, a human antibody specifically targeting IL‐23

  2015cites this paper
• Interleukin 23 in Crohn's Disease

  2014cites this paper
• Lymphotoxin beta receptor signaling limits mucosal damage through driving IL-23 production by epithelial cells

  2014cites this paper
• Enteric mucosa integrity in the presence of a preserved innate interleukin 22 compartment in HIV type 1-treated individuals.

  2014cites this paper
• IL-23 activates innate lymphoid cells to promote neonatal intestinal pathology

  2014cites this paper
• Nod/Ripk2 signaling in dendritic cells activates IL-17A–secreting innate lymphoid cells and drives colitis in T-bet−/−.Rag2−/− (TRUC) mice

  2014cites this paper
• The chemokine receptor CXCR6 controls the functional topography of interleukin-22 producing intestinal innate lymphoid cells.

  2014cites this paper
• The necroptosis adaptor RIPK3 promotes injury-induced cytokine expression and tissue repair.

  2014cites this paper
• Evaluation of the therapeutic potential of nanoencapsulated curcumin towards inflammatory bowel disease

  2014cites this paper
• Targeting Interleukins for the Treatment of Inflammatory Bowel Disease—What Lies Beyond Anti-TNF Therapy?

  2014cites this paper
• Murine Models of Inflammatory Bowel Disease (IBD)

  2014cites this paper
• The Dichotomous Pattern of IL-12R and IL-23R Expression Elucidates the Role of IL-12 and IL-23 in Inflammation

  2014cites this paper
• Physiological Effects of a Combination of Cinnulin with Probiotics

  2013cites this paper
• IL‐22 in tissue‐protective therapy

  2013influential citation
• b-Arrestin-1 De fi ciency Protects Mice from Experimental Colitis

  2013cites this paper